...
lnth-img

Lantheus Holdings Inc, Common Stock

LNTH

NMQ

$91.94

+$0.79

(0.87%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.44B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
15.392
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.31M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$50.2 L
$126.89 H
$91.94

About Lantheus Holdings Inc, Common Stock

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameLNTHSectorS&P500
1-Week Return0.03%-3.35%-2.97%
1-Month Return15.75%-3.49%-0.66%
3-Month Return-15.31%-12.6%2.71%
6-Month Return12.84%-6.91%7.21%
1-Year Return53.5%1.19%23.04%
3-Year Return234.08%-0.21%28.43%
5-Year Return336.77%33.09%82.88%
10-Year Return1432.33%93.55%184.63%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue347.34M339.41M425.21M935.06M1.30B[{"date":"2019-12-31","value":26.79,"profit":true},{"date":"2020-12-31","value":26.18,"profit":true},{"date":"2021-12-31","value":32.8,"profit":true},{"date":"2022-12-31","value":72.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue172.53M200.65M237.51M353.36M586.89M[{"date":"2019-12-31","value":29.4,"profit":true},{"date":"2020-12-31","value":34.19,"profit":true},{"date":"2021-12-31","value":40.47,"profit":true},{"date":"2022-12-31","value":60.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit174.81M138.76M187.69M581.70M709.54M[{"date":"2019-12-31","value":24.64,"profit":true},{"date":"2020-12-31","value":19.56,"profit":true},{"date":"2021-12-31","value":26.45,"profit":true},{"date":"2022-12-31","value":81.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin50.33%40.88%44.14%62.21%54.73%[{"date":"2019-12-31","value":80.9,"profit":true},{"date":"2020-12-31","value":65.72,"profit":true},{"date":"2021-12-31","value":70.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.98,"profit":true}]
Operating Expenses123.15M142.96M263.78M545.51M344.90M[{"date":"2019-12-31","value":22.58,"profit":true},{"date":"2020-12-31","value":26.21,"profit":true},{"date":"2021-12-31","value":48.36,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.23,"profit":true}]
Operating Income32.06M(4.20M)(76.09M)(13.44M)364.64M[{"date":"2019-12-31","value":8.79,"profit":true},{"date":"2020-12-31","value":-1.15,"profit":false},{"date":"2021-12-31","value":-20.87,"profit":false},{"date":"2022-12-31","value":-3.68,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(16.36M)(16.52M)(21.92M)(14.05M)45.92M[{"date":"2019-12-31","value":-35.64,"profit":false},{"date":"2020-12-31","value":-35.98,"profit":false},{"date":"2021-12-31","value":-47.74,"profit":false},{"date":"2022-12-31","value":-30.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income28.63M(11.48M)(75.04M)26.72M410.94M[{"date":"2019-12-31","value":6.97,"profit":true},{"date":"2020-12-31","value":-2.79,"profit":false},{"date":"2021-12-31","value":-18.26,"profit":false},{"date":"2022-12-31","value":6.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes(3.04M)1.99M(3.76M)(1.35M)84.28M[{"date":"2019-12-31","value":-3.61,"profit":false},{"date":"2020-12-31","value":2.37,"profit":true},{"date":"2021-12-31","value":-4.46,"profit":false},{"date":"2022-12-31","value":-1.6,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes31.67M(13.47M)(71.28M)28.07M326.66M[{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations31.67M(13.47M)(71.28M)28.07M326.66M[{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income31.67M(13.47M)(71.28M)28.07M326.66M[{"date":"2019-12-31","value":9.69,"profit":true},{"date":"2020-12-31","value":-4.12,"profit":false},{"date":"2021-12-31","value":-21.82,"profit":false},{"date":"2022-12-31","value":8.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)1.170.570.494.226.23[{"date":"2019-12-31","value":18.78,"profit":true},{"date":"2020-12-31","value":9.15,"profit":true},{"date":"2021-12-31","value":7.87,"profit":true},{"date":"2022-12-31","value":67.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

LNTH
Cash Ratio 1.10
Current Ratio 1.65
Quick Ratio 1.56

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LNTH
ROA (LTM) 17.00%
ROE (LTM) 45.53%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LNTH
Debt Ratio Lower is generally better. Negative is bad. 0.42
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.58

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LNTH
Trailing PE 15.39
Forward PE 12.00
P/S (TTM) 4.30
P/B 5.46
Price/FCF 40
EV/R 4.14
EV/Ebitda 9.50
PEG 0.61

FAQs

What is Lantheus Holdings Inc share price today?

Lantheus Holdings Inc (LNTH) share price today is $91.94

Can Indians buy Lantheus Holdings Inc shares?

Yes, Indians can buy shares of Lantheus Holdings Inc (LNTH) on Vested. To buy Lantheus Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LNTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lantheus Holdings Inc be purchased?

Yes, you can purchase fractional shares of Lantheus Holdings Inc (LNTH) via the Vested app. You can start investing in Lantheus Holdings Inc (LNTH) with a minimum investment of $1.

How to invest in Lantheus Holdings Inc shares from India?

You can invest in shares of Lantheus Holdings Inc (LNTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in LNTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lantheus Holdings Inc shares
What is Lantheus Holdings Inc 52-week high and low stock price?

The 52-week high price of Lantheus Holdings Inc (LNTH) is $126.89. The 52-week low price of Lantheus Holdings Inc (LNTH) is $50.2.

What is Lantheus Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lantheus Holdings Inc (LNTH) is 15.392

What is Lantheus Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lantheus Holdings Inc (LNTH) is 5.46

What is Lantheus Holdings Inc dividend yield?

The dividend yield of Lantheus Holdings Inc (LNTH) is 0.00%

What is the Market Cap of Lantheus Holdings Inc?

The market capitalization of Lantheus Holdings Inc (LNTH) is $6.44B

What is Lantheus Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Lantheus Holdings Inc is LNTH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top